glp-1 receptor agonist after roux-en-y gastric bypass Weight Reduction with Agonists and Paths for Discontinuation While Maintaining Weight Loss Efficacy of 12 months therapy

Explore whether the wide health benefits of GLP1 drugssuch as blood sugar control, weight loss, heart and brain protection.

The FDA approval of Eli Lilly's GLP-1 pill Foundayo comes nearly three months after Novo Nordisk's oral version of Wegovy hit the market.

This study investigates the effects of allulose, a rare sugar shown to reduce blood glucose, in a rat model of diet-induced obesity and T2D

After a few years of injectable dominance, oral formulations are emerging as a game-changer for adherence and ease of use thanks to their lack of cold-chain requirement, but also a game-changer for their ability to unlock the long-term maintenance opportunity [14]